Remember, Semaglutide GLP-1 is not a weight loss medication per se, but weight loss can be a beneficial side effect for those using it to manage their Type 2 diabetes
Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)
Understanding their mechanisms, benefits, and associated risks will remain essential as their role in clinical medicine continues to expand
Liraglutide (Saxenda, Victoza) Liraglutide is a daily GLP-1 medication with a 13-hour half-life
For more information, contact us or schedule an appointment online
GLP-1 exerts several key physiologic effects: Increases glucose-dependent insulin secretion Suppresses inappropriate glucagon release Delays gastric emptying Promotes satiety and reduces appetite Pharmacologic GLP-1 receptor agonists, including semaglutide, liraglutide, and tirzepatide, are engineered to resist DPP-4 degradation, allowing them to persist for hours to days
